pBABE-hygro p53 DD Citations (17)

Originally described in: Enumeration of the simian virus 40 early region elements necessary for human cell transformation.
Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA Mol Cell Biol 2002 Apr;22(7):2111-23. PubMed Journal

---

Articles Citing pBABE-hygro p53 DD

Articles
The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways. Labalette C, Nouet Y, Levillayer F, Armengol C, Renard CA, Soubigou G, Xia T, Buendia MA, Wei Y. PLoS One. 2008;3(11):e3761. doi: 10.1371/journal.pone.0003761. Epub 2008 Nov 19. PubMed
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway. Kurosu T, Wu N, Oshikawa G, Kagechika H, Miura O. Apoptosis. 2010 May;15(5):608-20. doi: 10.1007/s10495-010-0457-0. PubMed
Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA. Oncogene. 2011 Apr 14;30(15):1812-21. doi: 10.1038/onc.2010.556. Epub 2011 Jan 17. PubMed
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL, Drapkin R. Gynecol Oncol. 2011 Oct;123(1):5-12. doi: 10.1016/j.ygyno.2011.05.021. Epub 2011 Jun 17. PubMed
Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. Saleh AD, Savage JE, Cao L, Soule BP, Ly D, DeGraff W, Harris CC, Mitchell JB, Simone NL. PLoS One. 2011;6(10):e24429. doi: 10.1371/journal.pone.0024429. Epub 2011 Oct 11. PubMed
Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes. Herbet M, Salomon A, Feige JJ, Thomas M. PLoS Genet. 2012;8(5):e1002700. doi: 10.1371/journal.pgen.1002700. Epub 2012 May 10. PubMed
Expression of LY6D is induced at the surface of MCF10A cells by X-ray irradiation. Kurosawa M, Jeyasekharan AD, Surmann EM, Hashimoto N, Venkatraman V, Kurosawa G, Furukawa K, Venkitaraman AR, Kurosawa Y. FEBS J. 2012 Dec;279(24):4479-91. doi: 10.1111/febs.12034. Epub 2012 Nov 22. PubMed
Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC. Luo C, Sheng J, Hu MG, Haluska FG, Cui R, Xu Z, Tsichlis PN, Hu GF, Hinds PW. Cancer Res. 2013 Jul 15;73(14):4337-48. doi: 10.1158/0008-5472.CAN-12-4454. Epub 2013 May 6. PubMed
The role of miR-200a in mammalian epithelial cell transformation. Becker LE, Takwi AA, Lu Z, Li Y. Carcinogenesis. 2015 Jan;36(1):2-12. doi: 10.1093/carcin/bgu202. Epub 2014 Sep 19. PubMed
Metformin and erlotinib synergize to inhibit basal breast cancer. Lau YK, Du X, Rayannavar V, Hopkins B, Shaw J, Bessler E, Thomas T, Pires MM, Keniry M, Parsons RE, Cremers S, Szabolcs M, Maurer MA. Oncotarget. 2014 Nov 15;5(21):10503-17. PubMed
Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. Sadok A, McCarthy A, Caldwell J, Collins I, Garrett MD, Yeo M, Hooper S, Sahai E, Kuemper S, Mardakheh FK, Marshall CJ. Cancer Res. 2015 Jun 1;75(11):2272-84. doi: 10.1158/0008-5472.CAN-14-2156. Epub 2015 Apr 3. PubMed
Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive. Maupetit-Mehouas S, Montibus B, Nury D, Tayama C, Wassef M, Kota SK, Fogli A, Cerqueira Campos F, Hata K, Feil R, Margueron R, Nakabayashi K, Court F, Arnaud P. Nucleic Acids Res. 2016 Jan 29;44(2):621-35. doi: 10.1093/nar/gkv960. Epub 2015 Sep 22. PubMed
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis. Wassef M, Rodilla V, Teissandier A, Zeitouni B, Gruel N, Sadacca B, Irondelle M, Charruel M, Ducos B, Michaud A, Caron M, Marangoni E, Chavrier P, Le Tourneau C, Kamal M, Pasmant E, Vidaud M, Servant N, Reyal F, Meseure D, Vincent-Salomon A, Fre S, Margueron R. Genes Dev. 2015 Dec 15;29(24):2547-62. doi: 10.1101/gad.269522.115. Epub 2015 Dec 4. PubMed
Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis. Kumper S, Mardakheh FK, McCarthy A, Yeo M, Stamp GW, Paul A, Worboys J, Sadok A, Jorgensen C, Guichard S, Marshall CJ. Elife. 2016 Jan 14;5. pii: e12203. doi: 10.7554/eLife.12203. PubMed
Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells. Umezawa Y, Kurosu T, Akiyama H, Wu N, Nogami A, Nagao T, Miura O. Oncotarget. 2016 Jul 12;7(28):44448-44461. doi: 10.18632/oncotarget.9844. PubMed
Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors. Wassef M, Michaud A, Margueron R. Cell Cycle. 2016 Sep;15(17):2256-62. doi: 10.1080/15384101.2016.1208872. Epub 2016 Jul 15. PubMed
CENP-A overexpression promotes distinct fates in human cells, depending on p53 status. Jeffery D, Gatto A, Podsypanina K, Renaud-Pageot C, Ponce Landete R, Bonneville L, Dumont M, Fachinetti D, Almouzni G. Commun Biol. 2021 Mar 26;4(1):417. doi: 10.1038/s42003-021-01941-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.